Breaking News

Fujifilm to Acquire Biogen Subsidiary for $890M

Biogen will enter manufacturing agreements with the CDMO to supply TYSABRI and third-party products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Biogen has entered into a share purchase agreement with Fujifilm Corporation under which Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark, for up to $890 million in cash, subject to minimum purchase commitment guarantees and other contractual terms. The approximately 800 employees at the Hillerød subsidiary are expected to continue employment under Fujifilm ownership.   As part of the proposed transaction, Bio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters